Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Thursday, July 23, 2026

Snapshot: Jul 23, 2026 · 6:00 PM 100 stocks analyzed

Strong Down Day

Thu, Jul 23, 2026 Broad Selloff High

S&P 500 sank 1.67% in a broad selloff led by healthcare and financials, while high dispersion created a wild divergence between mega-cap declines and micro-cap lottery plays.

60% Broad selloff across all major indices with S&P 500 down 1.67%, NASDAQ Composite down 2.88%, and Dow down 1.60%, reflecting systematic risk-off momentum with healthcare stocks dominating the loser list at 33% of decline and VIX holding firm near 18.7 despite the sell pressure.
25% Extreme dispersion on the day with 50 gainers averaging 26.7% gains and 50 losers averaging -24.4% declines, creating a stock-pickers market where news-grounded winners like NVEC (56%, earnings beat), SAFT (35%, merger announcement), and DOMO (26%, acquisition) stood against catastrophic collapses like BACK (-98.75%), PRTO (-85%), and SXTC (-85%, equity offering dilution).
15% Technology paradoxically led the gainers list at 33% of top-50 winners—including beaten-down names like NVEC and mid-cap breakouts from earnings beats—while broader tech underperformed the market, highlighting a bifurcated sector where mega-cap weakness coexisted with micro-cap opportunism and strategic M&A announcement surges.

Technology drove 33% of gainers 5 names returned after long absences CJMB · 3-day gainers streak NVEC — first appearance SAFT — first appearance

Market Regime

Thu, Jul 23, 2026 Risk-Off conf: medium macro · prototype

-30

Headwind −100 … +100 · + tailwind / − headwind

VIX18.7 p87 Drawdown-2.7% Held1d · nascent SinceJul 23

Top drivers: VIX percentile ▼ Small-cap leadership ▼ VIX 5d momentum ▼

processId: history-market-regime

Market Indexes

Thu, Jul 23, 2026 13

S&P 500

7,408.30

−125.47

-1.67%

Dow Jones

51,711.65

−841.32

-1.60%

NASDAQ Composite

25,137.69

−744.26

-2.88%

NASDAQ 100

28,454.81

−570.96

-1.97%

DJ US Total Market

73,416.05

−1,199.97

-1.61%

Russell 1000

4,033.45

−69.51

-1.69%

S&P MidCap 400

3,769.22

−27.32

-0.72%

Russell 2000

2,940.16

−34.41

-1.16%

Russell 2500

1,250.45

−7.67

-0.61%

Russell 3000

4,213.78

−71.62

-1.67%

Nasdaq Financial-100

7,344.66

−198.78

-2.64%

NIFTY 50

23,869.60

−464.70

-1.91%

VIX

18.70

−0.07

-0.37%

Biggest Gainers

Thu, Jul 23, 2026 50

PAVS

Paranovus Entertainment Technology Ltd. - Class A Ordinary SharesConsumer Defensive

$5.90+$2.85

+73.3%

ADVB

Advanced Biomed Inc. Common StockHealthcare

$16.72+$6.35

+57.0%

NASDAQ · Mkt cap $14 M

No news headlines were published in the last 48 hours, so the 57% gain cannot be attributed to disclosed company-specific developments; the jump likely stems from technical trading, delayed news dissemination, or unverified market rumors.

Advanced Biomed Inc. posted a substantial 56.95% single-day gain with no corresponding news coverage in the most recent 48-hour window according to available Yahoo Finance feeds. This disconnect between price action and public headlines suggests several possibilities. First, material news may have been released but not yet indexed in this particular news feed or there may be a reporting delay. Second, the move could reflect pure technical factors such as short covering, options expiration activity, or algorithmic trading targeting a stock with smaller float. Third, for a biomedical company, catalysts often include clinical trial results, regulatory decisions, or partnership announcements—any of which could have circulated through specialized channels before mainstream indexing. Fourth, unverified social media or forum discussion could have driven retail trading volume. Without confirmed headlines, attributing causation is speculative, though biotech stocks are known for sharp moves on clinical or regulatory news.

NVEC

NVE CorpTechnology

$134.23+$48.24

+56.1%

WLDS

Wearable Devices LtdTechnology

$2.22+$0.76

+50.0%

NASDAQ · Mkt cap $6.0 M

No news headlines were found in the last 48 hours, so the 50% jump in WLDS stock is unexplained by public announcements. The move likely reflects either delayed disclosure, social media momentum, or technical trading activity in a thinly-traded micro-cap.

The absence of any news in the Yahoo Finance RSS feed over the past two days is notable given the magnitude of the gain. For a stock ranked fourth among daily gainers, one would typically expect corresponding headlines about earnings, FDA approvals, partnerships, or guidance revisions. The lack of any recent news suggests several possibilities. First, WLDS may be a low-float, thinly-traded micro-cap where momentum trading, retail interest, or technical factors can drive outsized moves independent of fundamentals. Second, relevant news may exist but not yet be widely syndicated through major RSS feeds, meaning an announcement could have been published on the company's investor relations page or a niche source without yet reaching mainstream financial media. Third, this could reflect accumulated speculative interest or social media-driven trading rather than any specific catalyst. Wearable device companies have been subject to cycles of retail enthusiasm, so reopened interest in the sector could amplify individual names.

ANY

Sphere 3D CorpFinancial Services

$1.76+$0.81

+49.4%

NASDAQ · Mkt cap $17 M

No news headlines were found in the last 48 hours to explain ANY's 49.39% jump on July 23, 2026, making the specific catalyst unclear.

Sphere 3D Corp (ANY) posted a substantial one-day gain without any reported news in the provided 48-hour window. This absence of obvious catalysts suggests the move was driven by either a delayed market reaction to older news, technical factors such as short covering or momentum buying in a thinly traded small-cap stock, or possibly an untracked announcement or rumor outside major news feeds. Sphere 3D is a microcap infrastructure software company historically subject to volatility and retail trading interest. Without access to intraday news, social media activity, insider transactions, or order flow data, we cannot pinpoint whether this was fundamentals-driven or purely technical, though the magnitude and rank suggest notable buying pressure.

JEM

707 Cayman Holdings LimitedConsumer Cyclical

$4.72+$1.74

+46.9%

NASDAQ · Mkt cap $2.8 M

No news headlines were found in the last 48 hours, so the 46.9% gain cannot be attributed to any identifiable company announcement or event. This jump likely reflects technical trading, short covering, or market rumors not captured in major news feeds.

The absence of any news in the 48-hour window preceding this substantial single-day move is notable. JEM, a Cayman-domiciled holding company with a relatively modest market price, is the type of micro-cap or small-cap security that can experience outsized intraday swings on limited volume or short-squeeze mechanics. Without access to headlines, we cannot rule out a delayed earnings report, an insider transaction disclosure, a technical breakout after consolidation, or retail trading interest concentrated on options or short positions. We also cannot confirm whether the catalyst is company-specific or if the move reflects broad sector momentum in financials or whatever sector JEM operates within.

GSUN

Golden Sun Education Group LimitedConsumer Defensive

$0.34+$0.12

+45.3%

NASDAQ · Mkt cap $3.5 M

No news headlines were found in the last 48 hours, so the 45% gain likely reflects either a delayed market reaction to an earlier announcement, technical trading activity in a micro-cap stock, or unconfirmed rumors not yet captured in mainstream sources.

Golden Sun Education Group is a micro-cap stock trading at $0.34, and the absence of recent news headlines despite a substantial single-day gain suggests the catalyst may not be a major institutional announcement. In stocks of this size and price range, significant moves often occur due to low liquidity amplifying small position changes, short covering, or delayed reactions to company updates that may have been released outside the primary news cycle. Without access to company press releases, SEC filings, or social media discussion that might have circulated in the past 48 hours, the underlying cause remains opaque. The timing and magnitude of the move warrant checking whether the company issued any earnings reports, guidance changes, or business developments that were not yet indexed by Yahoo Finance's RSS feed at the time of snapshot.

WBUY

WEBUY GLOBAL LTD. - Ordinary SharesConsumer Cyclical

$1.12+$0.33

+44.0%

NASDAQ · Mkt cap $4.2 M

Webuy announced expansion of its China inbound tourism business through new PATA membership and strategic partnerships to develop an AI-assisted travel ecosystem, driving a 44% single-day surge in a thinly-traded microcap stock.

Webuy Global released two nearly identical announcements on July 23 describing its membership in the Pacific Asia Travel Association and strategic initiatives to capture growth in China's inbound tourism market using AI-assisted travel solutions. For a sub-$2 NASDAQ stock with limited trading volume and analyst coverage, positive strategic announcements can trigger outsized percentage moves, particularly when they signal entry into a large addressable market or partnership validation. The announcements themselves lack specific financial metrics, customer wins, or revenue guidance, so the move reflects sentiment about the strategic direction rather than quantified business impact. The 44% gain ranks it among the day's biggest gainers, consistent with how microcap stocks respond to perceived positive pivots, though the sustainability and actual commercial significance of these partnerships remain unclear from the available information.

EHGO

Eshallgo Inc. Class A Ordinary SharesIndustrials

$2.70+$0.76

+43.2%

SKYQ

Sky Quarry Inc.Energy

$5.65+$1.65

+39.2%

NASDAQ · Mkt cap $12 M

No news headlines were found in the last 48 hours, so the 39% jump in SKYQ is unexplained by reported corporate events; the move likely reflects technical trading, delayed news arrival, or unverified market rumors.

The absence of any news headlines in the Yahoo Finance RSS feed over the past 48 hours makes it impossible to attribute SKYQ's 39% gain to a specific corporate catalyst such as earnings, regulatory approval, acquisition, or guidance revision. A move of this magnitude in a stock ranked tenth among daily gainers would normally correlate with material news, but none is evident here. The most likely explanations fall into a few categories: first, the news may exist but has not yet been indexed by the RSS feed or may appear on other platforms; second, the move could be technically driven, such as short covering, options expiration effects, or algorithmic trading; third, the jump might reflect an unverified rumor or social media momentum in retail trading communities. Without additional context on SKYQ's market cap, float, recent volatility profile, or short interest, it is difficult to distinguish between these scenarios.

LICN

Lichen China LimitedIndustrials

$1.16+$0.31

+36.7%

NASDAQ · Mkt cap $21 M

No news headlines were found in the last 48 hours for LICN, so the 36.74% gain cannot be attributed to a specific disclosed event; the move likely reflects technical factors, delayed news from earlier in the week, or undisclosed corporate developments.

The absence of recent news headlines makes it impossible to pin the cause of this substantial single-day gain to any specific catalyst. LICN is a microcap China-focused company trading on NASDAQ, and stocks in this category can be subject to significant intraday volatility driven by technical factors, short covering, retail trading momentum, or news that circulates informally before appearing in mainstream financial feeds. Possibilities include a delayed market reaction to an earlier announcement not captured in the 48-hour window, insider activity, or market noise common to illiquid securities. Without documented evidence of earnings, guidance, strategic partnerships, regulatory approvals, or other material events, any explanation remains speculative.

SAFT

Safety Insurance Group IncFinancial Services

$73.01+$25.95

+35.2%

NASDAQ · Mkt cap $1.5 B

Safety Insurance Group announced a definitive merger agreement with Mapfre for $1.54 billion on July 23, 2026, which directly triggered the 35.23% stock price surge as shareholders priced in the acquisition premium.

The headline establishes that Safety Insurance Group entered into a definitive merger agreement with Mapfre valued at $1.54 billion. This is a classic M&A catalyst that explains the sharp upward move. When a public company announces a merger at a set price, the stock typically rallies toward or to the acquisition price, reflecting the premium shareholders receive upon deal completion. The 35.23% jump represents the market repricing the equity to reflect the transaction value. Merger announcements of this magnitude and definitiveness are among the most straightforward explanations for single-day stock movements of this size. The timing alignment between the news release (July 23, 21:01 UTC) and the snapshot date (July 23) confirms the announcement drove the move the same trading day.

CJMB

Callan JMB Inc. Common StockIndustrials

$2.31+$0.61

+34.9%

NASDAQ · Mkt cap $15 M

No news headlines were found in the last 48 hours, so the 34.86% gain likely stems from a technical rebound, delayed disclosure, or market rumor not yet captured in major news feeds.

The absence of any recent headlines makes it impossible to identify a specific catalyst for CJMB's strong 34.86% gain on July 23, 2026. This is a micro-cap stock trading at $2.31, a category typically prone to high volatility and susceptible to technical factors such as short covering, options expiration, or low-volume price momentum. Without access to company filings, insider transactions, or sector developments released outside major news aggregators, we cannot rule out several possibilities: a delayed earnings announcement or guidance revision not yet syndicated to Yahoo Finance, a small-cap earnings surprise, a strategic announcement made through other channels, or pure technical mean reversion after a prior decline. For stocks in this price range and liquidity profile, retail trading activity and sentiment shifts can also drive outsized moves independent of fundamental news.

SBXD.WT

SilverBox Corp IV WT

$0.16+$0.04

+33.2%

TNMG

TNL Mediagene Ordinary SharesCommunication Services

$0.40+$0.10

+33.1%

NASDAQ · Mkt cap $1.1 M

No news headlines were found in the last 48 hours for TNMG, so the 33% gain on July 23 cannot be directly attributed to a specific announcement or event based on available information.

The absence of recent news coverage makes it difficult to pinpoint a definitive cause for the 33% single-day surge in TNMG. Stocks trading at $0.40 are often microcaps or penny stocks that can experience sharp moves on minimal volume, technical rebounds, or delayed news dissemination that may not immediately appear in major RSS feeds. Common catalysts for moves in this category include positive clinical or business developments at biotech firms, insider buying signals, short covering, retail investor attention, or broader market sentiment shifts in neglected small-cap segments. Without headline confirmation, however, any explanation remains speculative.

COPL.WT

Copley Acquisition Corp WT

$0.13+$0.03

+30.0%

NVCR

Novocure LtdHealthcare

$19.99+$4.44

+28.5%

NASDAQ · Mkt cap $2.0 B

Novocure reported record second-quarter revenue that beat estimates, raised full-year guidance, and achieved strong Optune patient growth with new European approval, triggering a 28.5% rally—the stock's best day in over 18 months.

The headline consensus is unambiguous: Novocure delivered a strong earnings beat on July 23, with record quarterly revenue, a 56.67% earnings surprise, and a 5.44% revenue beat. Management raised full-year financial guidance and reported record active patient levels for its flagship Optune wearable cancer treatment. The company also expanded commercial reach by securing European approval for Optune Pax. These concrete operational and financial achievements—combined with improved expense discipline and double-digit sales growth—directly explain the magnitude of the move. The stock had apparently underperformed or faced headwinds prior to this report, making the results a meaningful catalyst for a "breakout" that multiple outlets flagged as turning a corner after prolonged weakness.

THRM

Gentherm IncConsumer Cyclical

$45.60+$9.55

+26.5%

NASDAQ · Mkt cap $1.2 B

Gentherm beat Q2 earnings and revenue expectations, raised full-year guidance, announced record quarterly revenue of $416 million, completed a strategic medical acquisition, and authorized a new $400 million stock buyback program, driving the 26.49% gain.

The headlines establish a clear confluence of positive catalysts released on July 23, 2026. Gentherm reported a 27.12% earnings surprise and 8.29% revenue beat for Q2, with record quarterly product revenue of $416 million and 9.5% year-over-year revenue growth excluding foreign exchange effects. Management raised full-year 2026 guidance following stronger-than-expected automotive demand. Separately, the company announced the acquisition of Innovative Medical Equipment LLC to strengthen its medical product portfolio, plus a new $400 million stock repurchase authorization. The combination of better-than-expected financial performance, upward guidance revision, strategic M&A, and capital return signaling typically triggers strong single-day moves in small-to-mid-cap industrials, especially when all are announced simultaneously.

DOMO

Domo IncTechnology

$3.96+$0.81

+25.8%

NASDAQ · Mkt cap $176 M

Domo's board unanimously approved a definitive agreement for Progress Software to acquire the company's AI and data platform business for $400 million, announced late on July 22, driving a 25.76% surge as shareholders reacted to the takeover terms.

The news is unambiguous. On July 22, 2026, Domo announced that its Board of Directors had approved a definitive merger agreement under which Progress Software will acquire substantially all of Domo's assets and certain liabilities for $400 million. Pre-market trading on July 23 reflected an immediate 21% jump, and the stock continued climbing through the day to close up 25.76%. The takeover price of $400 million represents a significant premium relative to recent trading levels, and the transaction combines Progress's existing data platform capabilities with Domo's AI and data intelligence offerings. This is a classic M&A-driven equity rally where shareholders of the target company benefit from the acquisition premium embedded in the agreed purchase price.

LAWS

Lawson Products Inc-DE

$34.50+$7.02

+25.5%

RFAMR

RF Acquisition Corp III Rights

$0.15+$0.03

+25.0%

NASDAQ

No news headlines were found in the last 48 hours, so the 25% gain in RFAMR rights is unexplained by reported corporate events; the move may reflect technical trading, expiration dynamics, or market rumors not captured in the news feed.

RF Acquisition Corp III Rights is a SPAC rights instrument, a derivative security whose price is sensitive to movements in the underlying SPAC unit and prevailing arbitrage spreads between the rights and their redemption or exercise value. With no news reported in the provided headline set, the jump cannot be attributed to a specific corporate announcement, merger update, or redemption event. Rights-based securities often exhibit outsized percentage moves on low absolute prices and thin liquidity, and can be affected by expiration dates, changes in redemption assumptions, or technical rebalancing. It is also possible that market-moving information circulated outside Yahoo Finance's RSS feed, or that the move reflects positioning ahead of known SPAC-related events.

AIRE

reAlpha Tech Corp.Real Estate

$1.57+$0.31

+24.3%

NASDAQ · Mkt cap $7.9 M

No news headlines were found in the last 48 hours for AIRE, so the 24.31% gain on July 23 cannot be directly attributed to a disclosed catalyst. The move may reflect technical trading, market rumors, or a delayed announcement not yet indexed by Yahoo Finance.

The absence of recent news is a significant constraint on explaining this substantial single-day move. AIRE is a micro-cap stock trading at $1.57, a category historically prone to sharp price swings driven by technical factors, short covering, or retail momentum rather than fundamental catalysts. Stocks in this range often move sharply on small volume or speculative positioning. Without access to real-time trading data, SEC filings filed after the news feed cutoff, or company press releases not yet syndicated, we cannot identify a specific event. Plausible categories include: (a) a short squeeze or covering rally if AIRE had elevated short interest, (b) a delayed market reaction to an announcement made after the 48-hour window, or (c) pure technical/speculative momentum. This remains inference, not fact.

SLSN

Solesence, Inc. Common StockConsumer Defensive

$1.00+$0.19

+22.0%

NASDAQ · Mkt cap $66 M

No news headlines were available in the last 48 hours to explain the 21.99% gain, so the driver is unknown; the move may reflect technical trading, delayed disclosure, or sector momentum in a micro-cap stock.

The absence of any Yahoo Finance headlines in the 48-hour window preceding this 22% jump makes it impossible to attribute the move to a specific corporate event, earnings release, regulatory action, or M&A announcement. For a micro-cap stock trading at $1.00, common catalysts include short squeezes driven by low float and high short interest, gap fills or reversal trades after prior weakness, delayed SEC filings or conference presentations that haven't yet propagated to mainstream news feeds, or sector rotation into small-cap biotech or industrial names. Without access to social media sentiment, insider trading databases, or real-time market data showing options activity or short interest changes, we cannot determine whether this was driven by accumulation, technical setup, or speculative positioning. The rank as the 23rd biggest gainer suggests it was part of a broader micro-cap rally rather than a company-specific catalyst.

IAUX.WT

i-80 Gold Corp. WT

$0.84+$0.15

+21.6%

Skycorp Solar Group Limited Ordinary SharesEnergy

$9.77+$1.77

+21.6%

NASDAQ · Mkt cap $5.4 M

No news headlines were found in the last 48 hours, so the 21.56% gain likely reflects either a delayed market reaction to an earlier announcement, technical buying, or an undisclosed catalyst not yet captured in the news feed.

The absence of recent news headlines makes it difficult to pinpoint a specific cause for the substantial 21.56% single-day gain in PN. For a solar equipment or services company, typical catalysts include project contract wins, guidance raises, analyst upgrades, sector-wide momentum in renewable energy, or short-covering. The timing of the move without accompanying headlines suggests either a lag between an announcement and news indexing, a technical rebound or short squeeze, or market awareness of information not yet widely distributed. Solar stocks in particular can be volatile and responsive to renewable energy policy developments or commodity price shifts that may not always generate immediate headline coverage.

SOBR

SOBR Safe, Inc.Technology

$0.69+$0.12

+21.2%

NASDAQ · Mkt cap $1.6 M

No news headlines were found in the last 48 hours, so the 21% gain likely stems from technical trading, a delayed announcement, or sector momentum in micro-cap stocks.

SOBR is a micro-cap stock trading at $0.69 with no recent news provided by Yahoo Finance. The absence of identifiable catalysts makes pinpointing the cause difficult. Stocks at this price tier are sensitive to technical factors including short covering, retail interest, and low float dynamics. SOBR's previous business focus on alcohol detection technology and related safety solutions could have attracted renewed attention if rumors circulated about partnerships or product adoption, but this is speculation without evidence. Another possibility is that a press release or announcement was issued outside the Yahoo Finance RSS feed window, or that sector-wide momentum in safety or IoT stocks created tailwinds. Without substantive headline data, attribution remains uncertain.

SMTK

SmartKem, Inc.Technology

$0.23+$0.04

+21.2%

NASDAQ · Mkt cap $2.2 M

No news headlines were found in the last 48 hours, so the 21% gain on SMTK likely reflects technical trading, a delayed announcement, or market sentiment shift among retail traders in micro-cap stocks.

SmartKem is a micro-cap semiconductor company trading at $0.23 with extremely low liquidity typical of penny stocks. The absence of news in the Yahoo Finance RSS feed over the past 48 hours means we cannot attribute the 21% jump to a specific corporate announcement, earnings report, partnership, or regulatory event. Stocks in this price range often experience outsized percentage moves on minimal volume due to thin float and retail trading activity. The move could reflect technical chart behavior, delayed coverage of an older announcement, or discussion in online trading communities, but without headlines or structural catalysts we cannot pinpoint the specific trigger.

RELL

Richardson Electronics Ltd-United StatesTechnology

$21.79+$3.65

+20.1%

NASDAQ · Mkt cap $304 M

Richardson Electronics beat Q4 earnings and revenue estimates by large margins, with net income up 244% year-over-year and sales growth of 27.6%, triggering a 20% stock rally on strong execution and cash position for future growth.

The headlines establish a clear, multi-day earnings beat narrative. On July 22, RELL reported Q4 results with earnings surprises of plus 200 percent and revenue surprises of plus 19.55 percent, with fourth quarter GAAP net income jumping 244.4 percent to $3.7 million or $0.25 per diluted share. Net sales increased 27.6 percent year-over-year driven by broad-based demand across all three business units: Power & Microwave Technologies, Green Energy Solutions, and Cable. The company also declared a quarterly cash dividend and maintained a strong balance sheet. The stock initially jumped 17 percent on the earnings release itself on July 22, then gained additional ground on July 23 as the earnings call highlighted the strategic progress and robust revenue growth. This is a straightforward positive earnings surprise catalyst with credible magnitude.

ZIVO

Zivo Bioscience, Inc.Healthcare

$4.80+$0.80

+20.0%

NASDAQ · Mkt cap $17 M

No news headlines were found in the last 48 hours, so the 20% gain cannot be attributed to a specific announced catalyst. The move is likely driven by technical factors, investor sentiment, or information not captured in the headline feed.

Zivo Bioscience is a small-cap biotech company, and no material news was reported in the Yahoo Finance RSS feed for the 48-hour period covering this price surge. This absence of headlines is itself notable given the magnitude of the move. Small-cap biotech stocks frequently experience sharp swings on factors including clinical trial announcements, FDA decisions, partnership deals, insider activity, or shifts in investor sentiment toward the sector. It is also possible the catalyst was a delayed press release not yet indexed by the feed, a social media catalyst, or technical buying pressure from shorts covering or retail interest. Without access to the company's investor relations page or other real-time sources, the specific driver remains unknown.

LTCH

Latch, Inc.Technology

$0.18+$0.03

+19.7%

NASDAQ · Mkt cap $31 M

No news headlines were found in the last 48 hours, so the 19.69% gain on Latch likely reflects technical trading, retail sentiment, or undisclosed corporate developments that have not yet reached major financial news feeds.

Latch is a micro-cap smart access control company trading at $0.18, and stocks at this price point are often highly sensitive to technical factors, short-covering, and retail trading activity rather than fundamental catalysts. The complete absence of recent news headlines in the 48-hour window makes it difficult to identify a specific corporate event as the driver. Possible explanations include a delayed announcement not yet syndicated to major news sources, short-squeeze activity in a thinly traded stock, options expiration effects, or broader market sentiment shifts in the smart home or property technology sector. Without news confirmation or knowledge of Latch's specific technical setup, the exact cause remains speculative.

TMDE

TMD Energy LimitedEnergy

$1.02+$0.16

+18.6%

NYSE · Mkt cap $18 M

No news headlines were found in the last 48 hours, so the 18.6% gain likely reflects a technical bounce, delayed market reaction to an older announcement, or undisclosed corporate development.

TMD Energy Limited's 18.6% jump to $1.02 occurred without any recent news coverage in the provided RSS feeds. This disconnect suggests either that the catalyst originated before the 48-hour window, that it involves a corporate action not yet broadly reported by major financial news services, or that the move reflects technical factors such as short covering, options expiration effects, or momentum-driven volume in a low-priced stock. Energy companies can be sensitive to commodity price moves, geopolitical developments, or operational announcements that may not immediately trigger national headlines. Without corroborating news, the specific driver remains unknown, though the magnitude of the gain for a sub-$2 stock warrants caution about volatility and speculative activity.

IPCXR

Inflection Point Acquisition Corp. III Rights

$0.46+$0.07

+17.9%

NASDAQ

No news headlines were found in the last 48 hours, but IPCXR's 17.92% jump is consistent with typical SPAC rights behavior, which can spike on merger developments, redemption dynamics, or broad SPAC sentiment shifts that may not immediately surface in major news feeds.

No recent Yahoo Finance headlines were provided for IPCXR in the last 48 hours, so we cannot attribute the move to a specific named catalyst like an earnings release, merger announcement, or regulatory action. However, IPCXR is a SPAC rights offering, a security class that often exhibits outsized daily volatility based on developments in the underlying blank-check company's merger negotiations, shareholder votes, or redemption terms that may be discussed first in press releases, SEC filings, or investor calls before appearing in mainstream news aggregators. The timing of such information flow can lag headline pickup by hours or days. Alternatively, the move could reflect broad SPAC sector momentum, technical reversal, or accumulation ahead of a known near-term deadline or announcement. Without access to SEC filings or company press releases from the exact snapshot window, the specific trigger remains opaque.

EONR.WT

EON Resources Inc WT

$0.10+$0.01

+17.1%

HIHO

Highway Holdings LtdIndustrials

$1.32+$0.19

+16.8%

NASDAQ · Mkt cap $4.2 M

Highway Holdings announced a letter of intent to form a joint venture with Chinese battery energy storage manufacturer Guangdong Huahu, a material strategic development for the company that likely drove the 16.81% gain.

On July 22, HIHO announced it had signed a letter of intent with Guangdong Huahu New Energy Technology to establish a majority-owned energy storage venture. The announcement explicitly notes Huahu is a China-based manufacturer of battery energy storage systems and references the "WowTiger brand owner" in one headline, indicating an established operating entity with commercial presence. For a small-cap stock trading near $1.32, a strategic partnership involving joint venture formation with an active battery manufacturer represents material news that could reasonably attract investor interest, particularly if the market interprets this as a path to revenue generation or technology access in the growing energy storage sector. The LOI format suggests the deal is not yet closed, leaving execution risk, but the announcement itself was sufficient to trigger buying interest on the day after release.

THC

Tenet Healthcare CorpHealthcare

$199.03+$31.46

+15.9%

NYSE · Mkt cap $21 B

Tenet Healthcare reported strong Q2 2026 earnings and raised its full-year 2026 financial guidance, driving the 15.93% jump in THC stock price.

On July 23, 2026, Tenet Healthcare announced second quarter results that were evidently favorable enough to trigger an immediate and substantial market reaction. The company simultaneously raised its 2026 financial outlook, which is a concrete signal of improved operational performance and management confidence in future results. Both elements—a positive earnings report combined with raised guidance—are classic catalysts for equity rallies, particularly in healthcare operators where visibility into future profitability matters significantly to investors. The timing of the earnings announcement coinciding with the stock's +15.93% gain the same day establishes a direct causal link. No conflicting news or headwinds are present in the available headlines. The other news items mentioning "Tenet" appear to reference Tenet Fintech Group, a different company, so they are not relevant to THC.

CLF

Cleveland-Cliffs IncBasic Materials

$10.95+$1.50

+15.9%

NYSE · Mkt cap $7.0 B

Cleveland-Cliffs surged 15.87% after beating Q2 revenue estimates, reporting tripled EBITDA, returning to positive free cash flow, and issuing strong forward guidance driven by robust steel demand and higher pricing expected through the second half of 2026.

The stock jump is clearly anchored to Cleveland-Cliffs' Q2 2026 earnings release on July 23, which included multiple positive catalysts. The company beat revenue expectations by 1.88%, delivered a surprise-positive earnings result despite initial framing of an earnings miss, and most importantly highlighted tripled EBITDA and a return to positive free cash flow. CEO Lourenco Goncalves characterized the results as the strongest second-half performance forecast since 2021, citing improving automotive demand and elevated steel prices. The company also announced a CFO promotion to President, signaling confidence in management. These concrete operational and cash flow improvements, combined with management's explicit positive guidance for Q3 and beyond, provide substantial fundamental justification for the 15.87% rally. The move ranks CLF as the 36th largest gainer of the day, consistent with a major earnings-driven catalyst in a cyclical commodity business.

CHEK

Check Cap LtdHealthcare

$1.17+$0.16

+15.8%

NASDAQ · Mkt cap $49 M

No news headlines were found in the last 48 hours, so the 15.84% gain cannot be attributed to any publicly reported event. The move likely reflects technical factors, delayed news flow, or market-specific momentum.

Check Cap Ltd, a small-cap medical device company, posted a strong single-day gain without any corresponding news in the recent headline feed. This disconnect suggests either that relevant news was not captured in the RSS feed provided, that the move was driven by technical or sentiment factors unrelated to fundamental news, or that news broke outside the monitored window. Small-cap biotech and medtech stocks often respond to clinical trial data, regulatory submissions or approvals, partnership announcements, or shifts in short interest. Without access to the actual trigger, it is impossible to determine whether this was a catch-up move on delayed information, a squeeze-driven rally, or opportunistic buying on positive technical momentum.

LGCL

Lucas GC LimitedTechnology

$1.77+$0.25

+15.8%

NASDAQ · Mkt cap $10 M

No news headlines were published in the last 48 hours for LGCL, so the 15.80% gain on July 23 cannot be attributed to a specific announced catalyst based on available evidence.

The absence of recent news makes it impossible to pinpoint a definitive cause for the jump. LGCL's substantial single-day gain could reflect several common drivers for low-priced stocks: short covering or technical bounce following oversold conditions, delayed market reaction to older news not captured in the 48-hour window, insider activity or rumors not yet formalized, sector rotation, or pure technical momentum in a thinly traded security. Without either headline evidence or structural knowledge about LGCL's particular characteristics (short interest, float, institutional holdings, or recent chart patterns), we cannot distinguish between these possibilities or establish that any specific event triggered the move.

NEUP

Neuphoria Therapeutics IncHealthcare

$3.89+$0.53

+15.8%

NASDAQ · Mkt cap $22 M

Neuphoria Therapeutics surged 15.79% following announcement of an all-share merger agreement with Scancell Holdings, creating a combined cancer immunotherapy company to be listed on Nasdaq with $89 million in financing.

The merger agreement announced today represents a significant corporate event for Neuphoria shareholders. Scancell, a UK-based cancer immunotherapy developer, will acquire Neuphoria in an all-stock transaction, and the combined entity will trade on Nasdaq under Scancell's operations while maintaining Scancell's existing AIM listing. The deal includes an $89 million financing package, which signals investor confidence and provides capital for pipeline advancement. For Neuphoria shareholders, the announcement of an acquisition at a stated price typically provides clarity on valuation and de-risks the standalone company narrative. The gain reflects market approval of the merger terms and the strategic rationale of combining immunotherapy pipelines, though the all-stock nature means shareholders' ultimate value depends on the exchange ratio and post-merger execution.

CUEN

Cuentas Inc.Technology

$0.42+$0.06

+15.7%

NASDAQ · Mkt cap $5.4 M

No news headlines were found in the last 48 hours, so the 15.67% gain cannot be attributed to a specific reported catalyst. The jump may reflect technical trading, delayed news dissemination, or retail interest in a low-priced stock.

The absence of recent news headlines makes it impossible to pinpoint a concrete cause for CUEN's sharp 15.67% intraday gain. Micro-cap and penny stocks like CUEN, trading below $1, are frequently subject to momentum-driven moves, short covering, or social media-driven retail buying that may not generate immediate financial news coverage. It is also possible that a material announcement was made but has not yet been indexed by the news aggregator, or that the market is responding to developments from earlier in the week. Without headline evidence or structural insights into CUEN's current circumstances, the driver remains speculative.

MEDP

Medpace Holdings IncHealthcare

$605.90+$79.76

+15.2%

NASDAQ · Mkt cap $17 B

Medpace reported strong Q2 2026 earnings with 17.2% revenue growth, 34.5% net income growth, and a significant bookings beat, reversing earlier-year weakness and driving the 15% surge.

On July 22-23, Medpace released second-quarter results that exceeded Wall Street expectations on both earnings and revenue. The company reported $707.3 million in revenue, up 17.2% year-over-year, and net income rose 34.5%. Management highlighted a strong business environment, lower program cancellations, and record net bookings that beat expectations by a substantial margin. This represented a sharp turnaround from what the headlines describe as a poor first quarter and earlier malaise in the medtech sector. The combination of organic growth acceleration, margin expansion, and forward-looking strength in bookings (a leading indicator for clinical research firms) clearly justified the double-digit gain. The stock's ranking as the 41st biggest gainer of the day aligns with the magnitude of positive surprise disclosed in the earnings report.

AXINR

Axiom Intelligence Acquisition Corp 1 Right

$0.38+$0.05

+15.1%

NASDAQ

No news headlines were found in the last 48 hours, so the 15.12% gain on AXINR likely reflects either a technical or market-structure-driven move rather than a company-specific catalyst.

AXINR is a right associated with a SPAC acquisition entity (Axiom Intelligence Acquisition Corp 1). SPAC rights are often illiquid, low-volume securities that can experience outsized percentage swings on modest absolute price movements or technical trading. The lack of any news in the past 48 hours suggests this move was not driven by a merger announcement, deal termination, or corporate event. Possible drivers include: one, a delayed or embargoed announcement that has not yet appeared in the RSS feed; two, technical rebalancing or automated trading in a thinly-traded security; or three, renewed retail or speculative interest in the underlying SPAC. Without material news or disclosure, the specific cause remains unclear.

AKAN

Akanda Corp.Healthcare

$8.06+$1.25

+15.0%

NASDAQ · Mkt cap $2.6 M

No news headlines were found in the last 48 hours, so the 15% gain likely reflects technical momentum, a delayed market reaction to earlier news, or sector-level moves in cannabis or biotech, but the specific catalyst cannot be identified from available evidence.

Akanda Corp. is a cannabis company, and the stock jumped 14.97% to rank as the 43rd biggest gainer on the day. However, no recent news headlines were available to explain the move. This absence of reported news does not rule out a catalyst—it may indicate that either a catalyst occurred outside the monitored news feed, market participants are reacting to older news with a delay, or the move reflects broader sector momentum. Cannabis stocks can be volatile and responsive to regulatory developments, licensing approvals, earnings surprises, or shifts in state-level policy. Without specific news, the most probable explanations are technical buying, short covering, or a development that has not yet appeared in the headline feed provided.

CYCU

Cycurion, Inc. Common StockTechnology

$0.35+$0.05

+14.7%

NASDAQ · Mkt cap $7.9 M

Cycurion announced a scheduled Nasdaq listing hearing and reaffirmed commitment to maintaining its Nasdaq listing, which likely relieved delisting concerns and drove a 14.72% gain on July 22-23.

The headline indicates Cycurion faced potential delisting risk from Nasdaq, a serious governance threat for any public company. By announcing a scheduled hearing and explicitly reaffirming its commitment to maintaining listing status, the company signaled it is actively managing the compliance issue rather than facing imminent removal. For a micro-cap cybersecurity stock trading at $0.35, delisting risk is existential—removal would be catastrophic for liquidity and valuation. The news that the company has a planned hearing and is engaged with the exchange likely reduced tail-risk pricing that had previously depressed the stock. This is a classic relief rally where bad news (we need a hearing) is framed as manageable (we have a plan and are committed). The lack of additional detail about compliance violations or remediation specifics leaves some uncertainty, but the tone of the announcement appears designed to calm investors concerned about imminent delisting.

SPRC

SciSparc Ltd.Healthcare

$5.63+$0.72

+14.6%

NASDAQ · Mkt cap $3.9 M

No news headlines were found in the last 48 hours, so the 14.56% gain is unexplained by public reporting. The move likely reflects sector sentiment, technical trading, or untracked corporate developments.

SciSparc Ltd. is a small-cap biopharmaceutical company, and the absence of recent news headlines makes it difficult to pinpoint the exact catalyst for today's 14.56% gain. Small-cap biotech stocks are particularly sensitive to several types of unreported or delayed-to-report events: clinical trial announcements, partnership updates, insider transactions, or shifts in short interest that can drive sharp rallies. Another possibility is broad sector rotation into biotech or a technical breakout from a support level that attracted momentum traders. Without specific news, we cannot rule out that the move reflects market-moving information that has not yet propagated to major news feeds, a research update from a smaller outlet, or purely technical/sentiment-driven buying pressure unrelated to fundamentals.

LRHC

La Rosa Holdings Corp. - Common StockReal Estate

$1.05+$0.13

+14.1%

NASDAQ · Mkt cap $1.2 M

No news headlines were found in the last 48 hours, so the 14% gain on LRHC likely reflects either a delayed market reaction to an earlier announcement, technical/short-covering activity, or a small-cap volatility event unrelated to fundamental news.

The absence of recent news headlines makes it impossible to pinpoint a specific catalyst for this 14% single-day move. LRHC is a micro-cap equity trading near $1, a price range where stocks often experience outsized percentage swings on modest trading volume or technical rebounds. Possible drivers in such cases typically include: a reversal of prior selling pressure or short-covering activity; delayed market digestion of earnings or guidance released before the 48-hour window; a rumor or social-media catalyst not yet reflected in major news feeds; or a routine rebalancing by algorithmic traders. Without access to the company's most recent filings, conference calls, or insider transactions, and given the absence of published headlines, determining the actual catalyst requires additional data beyond what is presented.

ACU

Acme United CorpConsumer Defensive

$52.00+$6.25

+13.7%

NYSE · Mkt cap $237 M

Acme United beat both earnings and revenue estimates on July 23, posting a 154% earnings surprise and 3.89% revenue beat, which triggered the 13.66% stock jump as investors repriced the company higher on stronger-than-expected profitability.

The headlines establish that ACU reported Q2 2026 earnings on July 23 with a substantial 154.17% earnings per share beat relative to consensus estimates, combined with a 3.89% revenue beat. The company also reported 16% net sales growth and 6% net income growth year-over-year. The massive earnings surprise is the most plausible trigger for a single-day 13.66% gain, as equity markets reward unexpected earnings outperformance, particularly when the beat is this large. While the top-line revenue beat was modest, the earnings beat of over 150% suggests either significantly better operating leverage, margin expansion, or lower-than-expected tax rates that drove earnings far above what analysts had modeled. This type of earnings surprise commonly drives double-digit same-day moves in smaller-cap stocks.

SHOTR

RMG ML Sports Holdings Rights

$0.17+$0.02

+13.3%

NASDAQ

No news headlines were found in the last 48 hours, so the 13.33% gain likely reflects a technical bounce, options-related activity, or market microstructure effects common to low-priced rights offerings.

The absence of any news in the Yahoo Finance RSS feed over the past two days makes it impossible to attribute this move to a specific corporate event, earnings release, or strategic announcement. SHOTR is a rights offering vehicle tied to RMG ML Sports Holdings, a class of security that typically exhibits high volatility and thin trading. The 13.33% jump from $0.17 could stem from several mechanisms: a short squeeze or covering activity given the typically small float in rights offerings, technical mean reversion after prior weakness, end-of-week positioning, or delayed market reaction to an announcement that did not appear in the headline feed. Rights offerings are also sensitive to sentiment shifts around their underlying parent company or redemption deadlines. Without news, these remain reasonable hypotheses rather than confirmed drivers.

HODO

House of Doge Inc.Technology

$1.19+$0.14

+13.0%

NASDAQ · Mkt cap $33 M

No news headlines were found in the last 48 hours, so the cause of the 13.03% gain cannot be confirmed from available sources; the move may reflect technical trading, delayed news dissemination, or market sentiment shifts in this micro-cap stock.

House of Doge Inc. jumped 13.03% to rank among the top 50 gainers, yet Yahoo Finance returned zero headlines in the preceding 48 hours. This absence of identifiable news does not prove no catalyst occurred; it may indicate the headline feed lagged, the company issued an untracked announcement, or a rumor circulated off traditional channels. Micro-cap and penny stocks like HODO (trading at $1.19) are often driven by technical momentum, short-squeeze dynamics, social media sentiment, or speculative positioning rather than fundamental news. Without access to press releases, SEC filings, or social commentary, attributing the move to any specific event would be speculation. The timing and magnitude are consistent with either retail interest shifts or delayed information reaching the market, but neither can be confirmed here.

PETZ

TDH Holdings IncReal Estate

$1.36+$0.16

+12.9%

NASDAQ · Mkt cap $12 M

No news headlines were found in the last 48 hours for PETZ, so the 12.93% gain likely reflects a technical bounce, short covering, or undisclosed corporate event not yet captured by major financial news feeds.

The absence of any recent news coverage makes it difficult to pinpoint a specific catalyst for PETZ's strong single-day performance. TDH Holdings operates in the pet supply and services sector, which can be sensitive to sector rotation, retail sentiment shifts, or technical rebounds after weakness. For a stock trading at $1.36, the move could reflect short covering (common in lower-priced equities with high short interest), a technical bounce off support, delayed reaction to older company news not yet indexed by the RSS feed, or internal corporate developments such as management changes, financing announcements, or operational updates that simply haven't reached major news wires yet. Without corroborating headlines or stated structural factors, the true driver remains opaque.

Biggest Losers

Thu, Jul 23, 2026 50

BACK

IMAC Holdings, Inc.Healthcare

$0.00−$0.02

-98.8%

NASDAQ · Mkt cap $1.9 K

BACK collapsed 98.75% with no news reported in the last 48 hours, suggesting a delisting, reverse split, bankruptcy filing, or major undisclosed corporate event rather than a market-driven sell-off.

The absence of any headline coverage combined with a near-total wipeout is the key signal here. A 98.75% single-day loss on a NASDAQ-listed stock typically reflects a catastrophic corporate action rather than organic market repricing. The most common causes in this scenario are delisting notification, reverse stock split execution that collapses share value, filing for bankruptcy protection, or sudden loss of regulatory status. Small-cap healthcare and biotech stocks like IMAC Holdings (a regenerative medicine and orthopedic surgery company) are particularly vulnerable to delisting risk due to market cap and trading volume thresholds. It is also possible that a major announcement occurred but has not yet propagated to the Yahoo Finance RSS feed monitored here. Without access to SEC filings, company press releases, or exchange notices from the snapshot date, the specific trigger remains unknown.

PRTO

Proteon Therapeutics Inc

$4.04−$23.44

-85.3%

SXTC

China SXT Pharmaceuticals IncHealthcare

$0.35−$1.91

-85.2%

NASDAQ · Mkt cap $2.4 M

China SXT Pharmaceuticals announced a $9 million registered direct offering on July 23, which likely triggered the 85% single-day collapse due to immediate shareholder dilution and typical market reaction to RDOs by micro-cap biotech firms.

The company announced a registered direct offering (RDO) of $9 million in securities to institutional investors. RDOs are equity raises that involve dilution to existing shareholders and are often viewed negatively by the market, particularly in micro-cap and biotech stocks where the float is small and shareholder bases are concentrated. The timing of the announcement on the same day as the 85% drop, combined with the magnitude of the move, strongly suggests the market's immediate response to dilution news. The fact that this is the third-biggest loser on NASDAQ on that date further supports a company-specific catalyst rather than broad market movement. No other conflicting news is present to suggest alternative causes.

LESL

Leslie''s IncConsumer Cyclical

$1.32−$1.11

-45.7%

NASDAQ · Mkt cap $6.1 M

No news headlines were found in the last 48 hours for LESL, so the 45.68% drop cannot be directly attributed to any reported event; the decline likely stems from earnings disappointment, guidance cut, or broad market sector weakness typical of consumer discretionary retail stocks.

The absence of any Yahoo Finance headlines in the past 48 hours is notable given the severity of the move, ranking LESL as the fourth largest loser of the day. This suggests either that major news was released outside the RSS feed window, or the market reaction is driven by technical factors, an unconfirmed rumor, or a delayed response to information released earlier. Leslie's operates in the pool and spa retail sector, which is cyclical and sensitive to consumer spending, seasonal demand shifts, and housing activity. A 45.68% single-day drop of this magnitude typically signals a material negative catalyst such as quarterly earnings miss, significant guidance reduction, store closure announcements, or debt covenant concerns. Without confirming headlines, we cannot distinguish between these possibilities, though earnings-related disappointment would be the most common trigger for a stock in the retail consumer discretionary space to gap down this severely.

NVVE

Nuvve Holding Corp.Consumer Cyclical

$3.25−$2.49

-42.9%

NASDAQ · Mkt cap $729 K

No news headlines were available in the last 48 hours, so the 42.93% drop cannot be directly attributed to a specific announced event; the decline likely reflects either delayed news processing, technical selling, or a sector-wide or company-specific development not yet captured in the RSS feed.

Nuvve Holding Corp. is a vehicle-to-grid (V2G) and energy management technology company, a sector sensitive to regulatory changes, contract announcements, capital raises, and macroeconomic shifts in clean energy funding. The absence of any news in the last 48 hours is noteworthy given the magnitude of the move, which ranks this stock among the top five losers of the day. A decline of this severity typically correlates with a material corporate event—earnings miss, guidance reduction, financing dilution, contract loss, or sector headwinds—but none appear in the available headlines. This suggests the catalyst either broke after the RSS snapshot window, occurs in sources not indexed here, or reflects accumulated technical pressure and market re-rating that may have been triggered earlier or by rumor rather than formal disclosure.

ZCMD

Zhongchao IncHealthcare

$1.73−$0.84

-30.7%

NASDAQ · Mkt cap $6.2 M

Zhongchao announced a $5 million registered direct offering (RDO) of 4.5 million shares, which triggered the 30.65% drop due to immediate dilution concerns and typical negative market reaction to equity offerings.

The company announced a registered direct offering at $1.10 per share (implied from 4.5M shares for $5M), which is substantially below the stock's closing price prior to the announcement. This type of equity issuance typically causes sharp sell-offs because it dilutes existing shareholders, signals potential financial stress or cash needs, and the below-market pricing often becomes a reference point for shorts and bears. The timing on the announcement date itself (2026-07-23) combined with the magnitude of the drop (rank 6 biggest loser) suggests the market reacted swiftly and negatively to the dilution event. No other news or operational catalysts are evident in the headlines provided.

CISS

C3is Inc. - Common StockIndustrials

$0.96−$0.40

-30.1%

NASDAQ · Mkt cap $4.6 M

No news headlines were found in the last 48 hours, so the 30% drop cannot be attributed to a specific announced catalyst; the cause remains unclear without additional reporting.

C3IS dropped 30% on July 23 without any identified news in the 48-hour window. For a micro-cap stock trading at $0.96, large single-day moves can occur from several categories: (1) a delayed or unmonitored news event (earnings, insider trading, regulatory action), (2) technical selling or algorithmic liquidation, (3) an unconfirmed rumor or social media chatter, or (4) broad market pressure on the micro-cap or penny-stock sector. Without access to press releases, SEC filings, or confirmatory reporting, it is impossible to determine which factor drove the decline. The absence of coverage on Yahoo Finance does not rule out a real catalyst; it may simply indicate low institutional coverage.

ZVZZT

$21.00−$8.00

-27.6%

LBGJ

LBGJIndustrials

$0.03−$0.01

-27.1%

NASDAQ · Mkt cap $58 K

No news headlines were reported in the last 48 hours, so the 27% drop likely reflects either a delayed market reaction to earlier developments, technical selling pressure, or undisclosed company events that have not yet reached major news outlets.

The absence of recent news makes it difficult to pinpoint a specific catalyst for the sharp 27% decline in LBGJ. At a penny-stock price point of $0.03, this stock is highly susceptible to liquidity-driven moves, technical breakdowns, and rumors that may not immediately appear in major news feeds. The most probable explanations fall into a few categories: first, this could be a delayed reaction to company-specific developments announced more than 48 hours ago that the market is only now fully pricing in; second, technical selling pressure or a loss of support at key price levels could have triggered automated selling or short-covering; third, deteriorating sentiment toward the broader sector or a specific catalyst known within smaller trading communities but not yet reported by major financial media. Without access to news from before the 48-hour window or real-time trading commentary, it is impossible to identify the true cause.

PMI

Picard Medical, Inc.Healthcare

$0.09−$0.03

-25.9%

NYSE · Mkt cap $6.8 M

Picard Medical announced a reverse stock split on July 22 to maintain NYSE American listing compliance, which typically triggers sharp sell-offs as investors perceive the move as a sign of financial distress or dilution concerns.

The headline confirms that Picard Medical completed a reverse stock split following stockholder approval, explicitly stating the purpose was to support continued compliance with NYSE American listing standards. Reverse stock splits are commonly associated with struggling companies fighting delisting, and the market reaction of -25.89% reflects negative sentiment around this corporate action. While reverse splits mechanically adjust share counts without changing underlying economics, they are widely interpreted by retail and institutional investors as red flags signaling financial weakness. The timing and ranking as the tenth biggest loser suggests the market absorbed this news as material negative information. Without details on the split ratio or the company's underlying business performance, we cannot distinguish between reasonable concern about listing compliance issues versus overreaction, but the headline directly establishes the announced action that coincided with the sharp decline.

PLAG

Planet Green Holdings CorpIndustrials

$0.72−$0.22

-24.3%

NYSE · Mkt cap $12 M

No news headlines are available for the past 48 hours, so the 24% decline on July 23 cannot be directly attributed to a specific disclosed event. The drop likely reflects either technical selling pressure, delayed market reaction to prior news, or sector-related headwinds affecting penny stocks.

Planet Green Holdings is a micro-cap stock trading at $0.72, which typically exhibits high volatility and thin liquidity. The absence of recent news headlines in the provided data makes it impossible to link the sharp 24% decline to a specific catalyst like earnings, regulatory action, or business developments. For stocks of this size and structure, major moves often stem from technical factors including stop-loss cascades, short covering reversals, or shifts in retail interest. It is also possible that negative news was released through channels not captured in the Yahoo Finance RSS feed, or that the stock is reacting with a lag to earlier announcements. Without disclosure of underlying business fundamentals or recent events specific to Planet Green, attribution remains speculative.

LMFA

LM Funding America IncFinancial Services

$1.98−$0.62

-23.8%

NASDAQ · Mkt cap $1.5 M

No news headlines were found in the last 48 hours, so the 23.85% drop likely reflects either a delayed market reaction to an earlier announcement, technical selling pressure, or a negative development not yet captured in major financial feeds.

LMFA experienced a substantial single-day decline of nearly 24% with zero recent news coverage reported in the last 48 hours. This disconnect between the magnitude of the move and the absence of fresh headlines suggests several possibilities. First, the market reaction could be delayed, responding to news released more than two days ago that is not reflected in the current snapshot. Second, as a micro-cap security, LMFA may be vulnerable to technical selling, forced liquidations, or a reversal of earlier momentum without requiring a specific catalyst. Third, negative developments such as insider selling disclosures, covenant breaches, or operational announcements may exist but simply have not yet been picked up by major financial news aggregators. Given LMFA's positioning as a smaller lending-focused company, liquidity-driven moves and sector rotation are also typical drivers of such declines.

AIIOW

NWTN Inc. WarrantConsumer Cyclical

$0.03−$0.01

-22.7%

NUWE

Nuwellis, Inc.Healthcare

$2.19−$0.63

-22.3%

NASDAQ · Mkt cap $3.7 M

No news headlines appeared in the last 48 hours to explain the 22.26% drop in NUWE stock, so the catalyst remains unknown without additional information.

Nuwellis is a medical device company focused on fluid management and ultrafiltration solutions. A drop of this magnitude with zero reported headlines in the prior 48 hours suggests either the move was triggered by news that has not yet been picked up by major financial news feeds, a delayed market reaction to an earlier announcement, or a technical or sentiment-driven sell-off unrelated to company-specific fundamentals. Possible categories of catalyst include disappointing clinical trial data or regulatory setback, a guidance reduction or earnings miss announced after hours or before market open, debt covenant concerns, insider selling or share dilution announcement, or broad sector weakness in medical devices. Without access to the company's own disclosures or earnings calendar, any specific attribution would be speculation.

SSTK

Shutterstock IncCommunication Services

$5.76−$1.64

-22.2%

NYSE · Mkt cap $204 M

Shutterstock plunged 22-25% after suspending its quarterly dividend and announcing its Chief Accounting Officer's resignation, triggering investor concern over financial health and potential accounting issues.

The headlines establish two concrete negative catalysts announced on July 23rd: the suspension of Shutterstock's quarterly dividend and the resignation of the Chief Accounting Officer. Dividend suspensions typically signal financial stress or a pivot in capital allocation priorities, and they often provoke sharp selloffs from income-focused investors. The CAO's departure is particularly concerning because it raises questions about accounting controls, potential restatement risk, or other operational issues that may not yet be publicly disclosed. The timing—both announced the same day—compounds the negative signal. A positive announcement about expanded Unlimited downloads subscription appeared earlier on July 23rd but was evidently overwhelmed by these two developments. The magnitude of the decline (24.9% in afternoon trading, aligning with the -22.16% close) is consistent with a shock to investor confidence regarding dividend sustainability and financial transparency.

LBRT

Liberty Energy Inc.Energy

$19.61−$5.53

-22.0%

NYSE · Mkt cap $3.3 B

Liberty Energy beat Q2 earnings and revenue estimates while announcing a data-center power joint venture, yet fell 22% anyway, suggesting the market may have reacted negatively to capital expenditure guidance, valuation concerns, or disappointing forward guidance despite operational outperformance.

The headlines establish that Liberty Energy reported Q2 2026 results on July 22 with earnings beating by 28.57% and revenue beating by 9.25%, with sales up 14% year-over-year. Management also announced a strategic joint venture with PowerBridge to develop powered data center campuses, a potentially high-growth diversification. However, the stock fell 22% the day after earnings, which is unusual following a beat. This suggests either (1) management provided weak forward guidance that offset the beat, (2) the capital expenditure outlook was deemed excessive relative to returns, or (3) the market repriced the stock on valuation grounds despite solid results. The headlines do not disclose specific guidance figures, margins, or management commentary that would explain the selloff. The data-center power venture is mentioned as an expansion of ambitions but lacks details on expected returns or timeline.

VEEE

Twin Vee Powercats Co.Consumer Cyclical

$14.59−$4.11

-21.7%

NASDAQ · Mkt cap $6.2 M

Twin Vee Powercats declined 21.69% on July 23, 2026, but no news headlines from the last 48 hours were found, so the specific catalyst remains unclear without additional reporting or company disclosures.

The absence of recent news makes it impossible to pinpoint a definitive cause for the sharp decline. Twin Vee is a powersports and marine vessel manufacturer, and stocks in this sector can move significantly on several types of catalysts: earnings misses or disappointing guidance, supply chain disruptions, changes in consumer demand for recreational boats, shifts in financing availability, or broader market selloffs in discretionary spending stocks. A 21.69% one-day drop of this magnitude is typically tied to material news—earnings, guidance revision, or major operational disruption—rather than random drift. The lack of headlines in the RSS feed does not rule out the existence of an announcement; it may simply mean news was published through channels not captured by Yahoo Finance's RSS within the sampled window, or the move occurred before official disclosure. Without additional reporting, attributing this decline to a specific event would be speculation.

ACI

Albertsons Cos IncConsumer Defensive

$11.44−$3.17

-21.7%

KSCP

Knightscope, Inc.Industrials

$1.71−$0.45

-20.8%

NASDAQ · Mkt cap $26 M

Knightscope stock fell 20.79% with no material news reported in the last 48 hours, suggesting the move was driven by technical selling, a delayed announcement, or market sentiment unrelated to current headlines.

No headlines from the past 48 hours are available to explain the sharp 20.79% decline in Knightscope. This is a small-cap robotics and security company stock that can be subject to significant volatility and thin liquidity, which may amplify single-day swings on low volume or negative sentiment. Without news coverage, the drop could reflect several possibilities: a delayed announcement or earnings report released outside the Yahoo Finance feed window, accumulation of negative sentiment from prior week developments, technical breakdown below a support level, short covering unwinding, or broader sector rotation out of small-cap technology names. Knightscope's modest market capitalization makes it susceptible to momentum-driven selling and retail trading dynamics that can produce outsized single-day moves independent of company-specific catalysts.

AEHL

Antelope Enterprise Holdings LimitedIndustrials

$0.70−$0.16

-20.8%

NASDAQ · Mkt cap $6.5 M

No news headlines appeared in the last 48 hours, so the 20.78% decline cannot be attributed to a specific announced event; the drop likely reflects either technical selling pressure, a delayed market reaction to prior news, or broader sector weakness.

The absence of any recent news headlines makes it impossible to pinpoint a concrete catalyst for AEHL's sharp decline. A stock trading at $0.70 on NASDAQ and ranked among the day's largest losers could be responding to several generic categories of events: unannounced insider developments, a broader market selloff affecting micro-cap or penny stocks, short covering reversing an earlier rally, technical chart breaks triggering stop-loss orders, or delayed market digestion of older news that didn't surface in the 48-hour search window. Micro-cap stocks are also prone to wider daily swings and less reliable information flow than larger securities. Without headlines or structural context about AEHL's business, sector, or recent trading pattern, we cannot distinguish between these possibilities.

WETO

Webus International Limited Ordinary SharesTechnology

$0.11−$0.03

-20.3%

NASDAQ · Mkt cap $11 M

Despite positive announcements on July 22-23 including a $20 million commercial robotics agreement and Qualcomm partnership, WETO fell 20.35%, suggesting investors either sold on news, have concerns about deal execution, or are responding to an unrelated market or company-specific factor not capt…

The timing is puzzling. On July 22, Wetour Robotics announced a significant $20 million multi-site commercial framework agreement with non-refundable committed fees, a concrete revenue milestone. On July 23, it announced Qualcomm partnership integration for AI capabilities. Both are typically positive catalysts for small-cap tech stocks. Yet the stock dropped sharply on the same day as the Qualcomm news. Possible explanations include profit-taking after the July 22 announcement, investor skepticism about execution risk on a $20 million deal, disappointing guidance or analyst commentary released alongside the news, or a technical/sentiment reversal unrelated to these specific announcements. Without access to the full press release details, analyst coverage, or broader market conditions on July 23, the disconnect between news tone and price action remains ambiguous.

MLAC

Malacca Straits Acquisition Co Ltd

$0.38−$0.10

-20.1%

NASDAQ · Mkt cap $12 M

No news headlines were found in the last 48 hours, so the 20% drop cannot be attributed to a specific reported event; the decline likely reflects either technical selling, sector headwinds, or unreported developments in this SPAC.

MLAC is a blank-check acquisition company (SPAC), and the absence of any news headlines in the last 48 hours makes it difficult to pinpoint the driver of the sharp 20% decline. SPACs are particularly sensitive to changes in redemption risk, merger deal dynamics, timeline pressure, or broad shifts in SPAC sentiment. The stock's low price of $0.38 suggests it may already be trading significantly below its typical $10 SPAC floor, indicating prior distress. Possible explanations include adverse developments in a pending merger negotiation that have not yet reached public disclosure, redemption announcements, insider selling signals, or simple technical capitulation in a deeply underwater position. Without corroborating news, this remains speculative.

AVAT

Avalanche Treasury CorporationFinancial Services

$0.38−$0.10

-20.0%

NASDAQ · Mkt cap $17 M

No news headlines were published in the last 48 hours for AVAT, so the 20% single-day drop cannot be attributed to a confirmed catalyst based on available evidence.

The absence of recent news makes it impossible to pinpoint the cause of the sharp 20% decline. AVAT is a micro-cap stock trading at $0.38, which typically exhibits high volatility and is sensitive to several categories of events: liquidity stress or forced selling, delayed earnings misses or negative guidance from earlier in the week that market participants are just repricing, technical breakdown below a support level, broader sector rotation out of micro-cap or speculative names, or informal negative commentary on retail forums that precedes formal news publication. Without headlines or structural information about the company's recent financial condition or market position, the driver remains opaque. The timing and magnitude suggest either a fundamental disappointment or technical capitulation rather than routine noise.

FTFT

Future FinTech Group IncTechnology

$1.25−$0.29

-19.5%

NASDAQ · Mkt cap $1.8 M

No news headlines appeared in the last 48 hours for FTFT, so the 19.46% drop cannot be directly attributed to a specific announced event; the decline likely stems from technical selling, sector rotation, or undisclosed developments.

The absence of news in the Yahoo Finance RSS feed over the past 48 hours means we cannot point to an earnings miss, guidance cut, regulatory action, or business announcement as the direct cause of FTFT's steep 19.46% decline on July 23, 2026. For a micro-cap fintech stock trading at $1.25, typical catalysts include quarterly earnings results, changes in regulatory environment for financial technology, shifts in cryptocurrency or blockchain sentiment (if relevant to the company's business), short covering or short attacks, and liquidity-driven selloffs. The stock's rank as the 24th biggest loser suggests a broad selling day in this sector or capitalization tier, which could indicate sector-wide pressure rather than company-specific news. Without access to after-hours announcements, social media, or real-time trading alerts, we cannot determine whether the move was driven by macroeconomic factors, technical support breaks, or undisclosed company developments.

JAGX

Jaguar Health IncHealthcare

$1.07−$0.25

-18.9%

NASDAQ · Mkt cap $4.5 M

Jaguar Health fell 18.94% on July 23, but the only recent news is a positive compassionate-use announcement from July 22 that should support the stock, suggesting the decline was likely driven by other factors such as broader market conditions, sector rotation, or undisclosed company-specific con…

The headline from July 22 announces an additional infant patient receiving Jaguar's crofelemer through compassionate use for a rare intestinal failure disease, which is typically viewed as a positive development for a small-cap biotech company. This news would not reasonably explain a sharp 18.94% single-day decline. The timing gap between the announcement and the price drop, combined with the unrelated nature of the news to the magnitude of the move, suggests the decline stems from other sources. For small-cap biotech stocks like JAGX, common catalysts for large single-day drops include disappointing trial data or clinical setbacks not yet reflected in headlines, sector-wide selling pressure in biotech, short covering reversals after a previous rally, or undisclosed insider transactions or guidance issues. Without additional news in the provided feeds, the specific trigger remains unclear.

RAIN

Rain Therapeutics Inc.Industrials

$1.46−$0.34

-18.9%

NASDAQ · Mkt cap $10 M

No news headlines were found in the last 48 hours for RAIN, so the 18.89% drop likely reflects either a delayed market reaction to an earlier announcement, a sector-wide biotech decline, or deteriorating clinical/financial fundamentals not yet picked up by major news feeds.

The absence of any headline in the most recent 48 hours makes it impossible to pinpoint a specific catalyst for the 18.89% single-day decline. Rain Therapeutics is a clinical-stage biotech company, and such stocks are typically sensitive to trial data releases, regulatory setbacks, financing announcements, or shifts in cash runway expectations. The size and rank of this move (number 26 biggest loser) suggests a material event rather than random noise. Possible explanations include: first, a trial result or regulatory decision announced slightly outside the 48-hour window that the market is still repricing; second, a broader biotech sector selloff affecting smaller-cap names disproportionately; or third, an internal development or financing concern that has not yet reached mainstream news outlets. Without headline confirmation, all remain speculative.

RGP

Resources Connection IncIndustrials

$3.77−$0.86

-18.5%

NASDAQ · Mkt cap $146 M

Resources Connection reported Q4 fiscal 2026 results showing an 18.3% revenue decline that missed analyst expectations, triggering the 18.51% stock drop as investors react to weakening demand despite the company's positive earnings surprise and stable outlook.

The company reported Q4 revenue of $106.1 million, representing an 18.3% decline from the prior year period, which fell short of consensus estimates by 0.85%. While RGP delivered a positive earnings surprise of 36.36%, the headline revenue miss appears to have dominated investor reaction. The earnings call indicates demand conditions are broadly stable and management is investing in sales and AI opportunities, suggesting management confidence in future recovery. However, the magnitude of the revenue decline—nearly one-fifth year-over-year—signals a material contraction in the company's core business that likely overshadows the beat on the bottom line. Professional services firms trading at lower valuations are particularly sensitive to top-line weakness, as investors interpret revenue declines as leading indicators of future profitability pressures.

RBOT

D8 Holdings Corp.Healthcare

$0.11−$0.03

-18.4%

NYSE · Mkt cap $257 K

Vicarious Surgical, likely a major holding or peer benchmark for RBOT, announced shareholder approval to dissolve and liquidate assets, signaling distress in the surgical robotics space and damaging investor confidence in the sector broadly.

The headline establishes that Vicarious Surgical—described as a well-financed surgical robotics developer that once competed with Intuitive—has been approved by shareholders for dissolution and asset liquidation. This is a concrete negative event in the robotics sector. RBOT appears to operate in or near this same market space. While the news does not name RBOT directly, the dissolution of a rival or peer company in surgical robotics typically signals sector headwinds: failed commercialization, unmet clinical or regulatory milestones, or simply unsustainable unit economics. Investors in robotics companies often view such failures as validation of sector-wide challenges rather than isolated company issues. The timing of RBOT's 18% drop on the day of this announcement, combined with its ranking as the 28th biggest loser, suggests the market is repricing robotics exposure. This is most likely contagion from a peer's failure rather than news specific to RBOT's own operations.

GIPR

Generation Income Properties Inc.Real Estate

$0.74−$0.17

-18.3%

NASDAQ · Mkt cap $253 K

No news headlines were published in the last 48 hours, so the 18.35% decline cannot be attributed to a disclosed event; the drop likely stems from broader market sentiment, technical selling, or undisclosed news flow.

Generation Income Properties is a micro-cap real estate investment trust trading at $0.74, and the absence of any news in the last 48 hours means the reported decline cannot be tied to a specific company announcement, earnings release, or regulatory action. For small-cap REITs, typical catalysts include changes in interest rate expectations, portfolio performance deterioration, dividend cuts, liquidity concerns, or shifts in commercial real estate sentiment. The stock's very low price and penny-stock-like characteristics suggest it may be subject to higher volatility and retail trading dynamics that can amplify moves on limited news. Without disclosed information, the decline could reflect delayed market reaction to older news, technical support breaks, insider trading signals, or broader sector weakness in the REIT space that has not yet surfaced in public headlines.

KALA

Kala Pharmaceuticals IncHealthcare

$0.61−$0.13

-17.6%

BIYA

Baiya International Group Inc. Ordinary SharesTechnology

$2.68−$0.52

-17.2%

NASDAQ · Mkt cap $71 M

No news headlines were available in the last 48 hours to explain the 17.22% drop in BIYA stock, so the cause remains unclear from public announcements.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for BIYA's steep decline. The stock ranked as the 31st biggest loser on the day, suggesting a material move. Possible explanations for a gap-down move without accompanying news include delayed market reaction to a previous announcement, internal company developments not yet widely reported, sector-wide pressure affecting micro-cap or emerging-market-linked stocks, short squeeze reversal, or technical selling driven by stop-loss triggers around support levels. Baiya International Group is a smaller-cap name where trading can be more volatile and news dissemination may lag actual market-moving events. Without confirming headlines, the actual cause could range from operational setbacks to regulatory concerns to simple profit-taking.

EVH

Evolent Health IncHealthcare

$4.62−$0.94

-16.9%

NYSE · Mkt cap $482 M

Citi downgraded EVH from Buy to Neutral on July 23, reducing its price target, which triggered a 13% afternoon sell-off that contributed to the stock's 16.91% daily loss.

The headline explicitly documents a Wall Street downgrade by Citi that shifted its rating from Buy to Neutral and lowered the price target, though the exact new target is not stated in the snippet. This downgrade occurred on the same day as the stock's sharp decline and clearly represents a material shift in analyst sentiment. The 16.91% total daily loss exceeds the reported 13% afternoon drop, suggesting either that the decline accelerated further after the initial downgrade announcement or that other selling pressure accumulated before the Citi call. The second headline about AI stocks appears tangential to EVH's healthcare focus and does not directly explain the move. Without visibility into the specific reasons Citi cited for the downgrade, the precise catalyst behind the rating change remains unclear, though analyst downgrades typically reflect either deteriorating fundamentals, guidance concerns, or valuation reassessment.

HYFT

ImmunoPrecise Antibodies Ltd.Healthcare

$1.19−$0.24

-16.8%

NASDAQ · Mkt cap $67 M

MindWalk Holdings (HYFT) fell 16.78% despite announcing fiscal 2026 results showing 46% revenue growth and a successful ReefIQ AI drug discovery platform demo, likely because the company missed Q4 revenue estimates by 8.8% and reported a net loss, disappointing near-term investor expectations.

The news headlines reveal a mixed earnings picture that likely triggered the sell-off. On the positive side, fiscal 2026 showed strong 46% year-over-year revenue growth and the company regained NASDAQ compliance while pivoting to Bio-Native AI infrastructure. However, the more recent Q4 earnings announcement states the company missed revenue estimates by 8.8% and delivered a -20% earnings surprise (a net loss), which directly contradicts momentum from the full-year results. Additionally, while the ReefIQ platform demonstration on July 23 was positioned as a positive milestone for AI drug discovery, it came after the earnings miss had already been disclosed, suggesting it could not offset investor disappointment over near-term financial underperformance. For biotech and AI companies trading at micro-cap levels, quarterly misses often trigger sharp repricing regardless of longer-term strategic progress.

AGL

agilon health, inc.Healthcare

$99.53−$19.99

-16.7%

NYSE · Mkt cap $1.5 B

Citi downgraded Agilon Health from Neutral to Sell on valuation concerns on July 23, which triggered the 16.73% decline as the stock fell sharply during afternoon trading.

The headline from July 23 at 17:08 UTC explicitly states that shares fell 10.8% in the afternoon session following a Citi downgrade to Sell with valuation concerns cited as the reason. The stock's total decline of 16.73% by day's end suggests additional selling momentum beyond the initial downgrade reaction, which is typical when a major analyst initiates a negative call on a healthcare stock. The second headline mentions analyst calls across sectors but does not provide details specific to Agilon. Valuation downgrades on healthcare services companies often reflect concerns about growth multiples being unsustainable relative to earnings or cash flow, though the headline does not specify which metrics triggered Citi's reassessment.

TAOP

Taoping IncTechnology

$1.05−$0.21

-16.7%

NASDAQ · Mkt cap $7.9 M

No news headlines were available in the last 48 hours to explain TAOP's 16.67% drop, so the catalyst remains unclear. The loss ranks it among the day's 35 biggest losers, suggesting a material negative event or market shift.

Yahoo Finance returned zero headlines for TAOP in the last 48 hours, making it impossible to identify a specific news-driven catalyst for the sharp 16.67% decline. For a micro-cap stock trading at $1.05, common sources of large single-day moves include delayed earnings announcements, sudden insider selling, delisting warnings, reverse split announcements, or negative analyst downgrades that may not appear immediately in mainstream financial news feeds. Additionally, illiquid low-priced stocks are more prone to technical selling, short squeezes unwinding, or shifts in retail sentiment. Without access to company filings, press releases, or regulatory announcements filed today, the root cause cannot be determined from the available evidence.

ZNB

Color Star Technology Co., Ltd.Communication Services

$0.27−$0.05

-16.7%

NASDAQ · Mkt cap $448 K

No news headlines were available in the last 48 hours to explain the 16.67% decline in ZNB stock, so the cause remains unclear without additional context or intraday catalysts.

Color Star Technology Co., Ltd. experienced a substantial single-day loss with no corresponding news coverage in the provided sources. The absence of headlines means we cannot point to a specific earnings announcement, contract loss, regulatory action, or guidance revision. Micro-cap stocks trading near $0.27 per share are typically prone to high volatility from multiple sources: thin liquidity can amplify small trades into large percentage moves, sector rotation away from technology or consumer discretionary could have triggered selling, insider transactions or lock-up expirations sometimes drive unexplained moves, or deteriorating market sentiment toward Chinese-listed companies on U.S. exchanges may have played a role. Without concrete news, identifying the precise catalyst requires either real-time order flow data or announcements released outside the Yahoo Finance RSS feed window.

DFNS

Defense Industries International IncIndustrials

$3.90−$0.77

-16.5%

NYSE · Mkt cap $27 M

DFNS dropped 16.49% on July 23, 2026, but no news headlines from the prior 48 hours are available to explain the move, leaving the cause unclear.

The absence of any recent news headlines makes it difficult to pinpoint a specific catalyst for the sharp 16.49% decline. Defense stocks can be sensitive to several drivers: geopolitical developments, defense spending announcements, quarterly earnings misses, contract losses, or shifts in government procurement policy. Without headline information, the drop could reflect a delayed market reaction to an earlier announcement, a technical sell-off following a run-up, sector-wide weakness in defense equities, or negative rumors. Given DFNS's rank as the 37th biggest loser of the day, the move was substantial but not necessarily isolated. Investors should check company filings, earnings call transcripts, or official press releases directly to determine whether the decline stems from fundamental news or other market dynamics.

GFUZ

General Fusion Group Ltd.Industrials

$6.97−$1.28

-15.5%

NASDAQ · Mkt cap $649 M

No relevant news headlines were found in the last 48 hours, so the 15.52% drop on GFUZ likely resulted from technical selling, sector rotation, delayed news digestion, or broader market conditions unrelated to company-specific catalysts.

The absence of recent news headlines creates a clear gap between the stock's significant decline and any identifiable catalyst. GFUZ dropped roughly 16% on July 23, 2026, but no earnings announcements, regulatory decisions, partnership changes, or guidance revisions appear in the news sources checked. This disconnect suggests several possibilities. First, the selling may be purely technical—a breakdown of support levels or algorithmic triggered decline. Second, the stock may be responding to sector-wide headwinds in fusion energy, clean technology, or a broader market correction not evident from company-level news alone. Third, material news may exist but was not yet indexed by Yahoo Finance RSS at the time of this snapshot. Without visible news hooks, investors should consider whether prior announcements from days or weeks earlier are now being repriced, or whether the move reflects changed sentiment toward General Fusion's business model, competitive position, or technical feasibility.

WCT

Wellchange Holdings Company LimitedTechnology

$0.82−$0.14

-15.4%

NASDAQ · Mkt cap $4.1 M

No news headlines were found in the last 48 hours for WCT, so the 15.43% drop cannot be attributed to a specific announced event; the decline likely reflects either technical selling pressure, a delayed market reaction to prior news, or broader sector weakness.

The absence of recent news headlines makes it difficult to pinpoint a precise catalyst for WCT's sharp 15.43% intraday decline. When micro-cap or lower-priced stocks experience single-day drops of this magnitude without accompanying news, the causes typically fall into a few categories: technical selling or stop-loss cascades triggered by price action itself, delayed market reaction to older news that may not be indexed in the 48-hour RSS feed, short-selling pressure or negative rumors circulating on less-formal channels, or sector-wide headwinds affecting similar securities. Given that WCT trades on NASDAQ and is ranked 39 on the biggest losers list, it is also possible that the move is part of a broader market dislocation in smaller-cap or speculative securities that day. Without access to company-specific news, earnings calendars, or insider activity, attribution remains speculative.

MBLY

Mobileye Global IncConsumer Cyclical

$7.47−$1.32

-15.0%

NASDAQ · Mkt cap $7.1 B

Mobileye beat Q2 earnings estimates and raised full-year guidance, but founder and CEO Amnon Shashua announced his resignation, triggering a sharp 15% sell-off as investors weighed leadership uncertainty against the bullish financial results.

The earnings headlines present a paradox. Mobileye reported strong profitability with a 46% increase in adjusted operating profit, beat both earnings and revenue estimates, and raised its full-year revenue guidance. The stock initially surged nearly 10% in premarket trading on this news. However, the company simultaneously announced that founder and longtime CEO Amnon Shashua will step down, a major leadership transition occurring precisely as Mobileye accelerates its robotaxi and robotics initiatives. This announcement appears to have reversed the premarket gains and driven the stock into the red by day's close. Investors likely view leadership continuity as critical given the company's pivotal stage in scaling autonomous driving technology, and Shashua's departure may have overshadowed the otherwise solid financial beat and raised guidance in the market's calculus.

SPWR

SunPower CorpTechnology

$0.50−$0.09

-14.9%

NASDAQ · Mkt cap $46 M

SPWR dropped 14.90% on July 23 following a prior 11.64% decline on July 22; the recent headline references CSLM Acquisition Corp. and notes the stock moved larger than the broader market, but does not specify a fundamental trigger for the selloff.

The provided headline from July 22 acknowledges that SPWR (listed as CSLM Acquisition Corp.) experienced a significant drop relative to the market but does not disclose the underlying cause. The stock's ticker and entity name suggest this may be a SPAC or recently acquired company, which are sensitive to valuation, redemption activity, or sponsor-related announcements. The consecutive daily declines and above-market magnitude of the move indicate investor concern beyond general market weakness. Without substantive news detailing earnings misses, guidance reductions, insider selling, shareholder disputes, or deal-related complications, the specific catalyst remains unclear. The weakness could stem from sector rotation in renewables, SPAC-related redemption pressure, or an announcement not captured in the available headline feed.

BNRG

Brenmiller Energy LtdUtilities

$0.78−$0.13

-14.6%

BACCR

Blue Acquisition Corp. Right

$0.51−$0.09

-14.5%

NASDAQ

No news headlines were found in the last 48 hours to explain the 14.54% drop in BACCR, so the decline is likely driven by broader market weakness, typical SPAC rights offer dynamics, or undisclosed trading activity.

Blue Acquisition Corp. Right (BACCR) is a SPAC rights warrant, a security that typically trades with low volume and high volatility. The absence of news in the past 48 hours means we cannot anchor the decline to a specific corporate event, earnings surprise, or deal announcement. SPAC-related securities often experience price swings tied to the underlying acquisition timeline, investor redemption concerns, or shifts in the parent company's deal prospects. Alternatively, the move could reflect technical selling, rotation out of blank-check proxies, or illiquidity-driven volatility common to low-priced warrant structures. Without headline confirmation, we cannot identify the precise catalyst.

FXHO

Utime Ltd.Technology

$12.52−$2.11

-14.4%

NASDAQ · Mkt cap $54 M

No news headlines were found in the last 48 hours, so the 14.39% drop cannot be directly attributed to a disclosed event. The decline likely reflects either delayed market reaction to an earlier announcement, technical selling, or undisclosed developments.

The absence of recent news for Utime Ltd. makes direct cause identification impossible. FXHO is a microcap NASDAQ-listed security, and stocks in this category often experience sharp moves on limited information flow, including pre-market announcements not yet reflected in news aggregators, insider selling, changes in short interest, or liquidity-driven technical selling. Without access to the company's investor relations channels, SEC filings made in the past 48 hours, or real-time trading data, it is reasonable to infer that either a material development occurred but has not yet reached major financial news outlets, or the move is driven by technical factors or shifts in retail or institutional positioning. The ranking as the 44th biggest loser suggests this was a broad sell-off rather than an isolated move, which could point to sector weakness or a market-wide trigger affecting smaller caps.

CSLR

Complete Solaria IncTechnology

$0.50−$0.08

-14.4%

NASDAQ · Mkt cap $16 M

No news headlines were available in the last 48 hours, so the 14.38% drop cannot be directly attributed to a public announcement or disclosure. The decline was likely driven by technical selling, broader market conditions, or undisclosed corporate developments.

Complete Solaria Inc experienced a significant single-day decline with zero news coverage in the preceding 48 hours according to Yahoo Finance RSS. This absence of headlines suggests the move was not triggered by an earnings announcement, regulatory action, merger news, or formal guidance change. For a stock trading at $0.50 on NASDAQ, typical catalysts might include dilution from secondary offerings, insider selling, short seller pressure, or deterioration in an illiquid trading environment where modest volume can create outsized percentage moves. Alternatively, the decline could reflect delayed market pricing of information announced before the 48-hour window, or reaction to news published on platforms outside the RSS feed monitored here. Without specific corporate context or structural details about CSLR, the root cause remains opaque.

FLYE

International Jet Engine Supply, Inc.Consumer Cyclical

$1.65−$0.27

-14.1%

NASDAQ · Mkt cap $2.9 M

Fly-E Group received a Nasdaq non-compliance notification on the same day it reported fiscal 2026 results, triggering a 14% drop; the listing rule violation likely signals imminent delisting risk unless remedied.

On July 23, Fly-E Group announced two material events: fiscal 2026 financial results and a Nasdaq notification of non-compliance with Listing Rule 5250(c)(1). The non-compliance headline is the primary driver of the sharp decline. Rule 5250(c)(1) typically concerns minimum bid price requirements, stockholder equity thresholds, or other quantitative listing standards. When a company receives such a notification, it generally has 180 days to regain compliance or face delisting proceedings, which creates severe uncertainty for equity holders and often triggers immediate selling. The timing—both announcements released on the same day—suggests the financial results may have revealed deteriorating metrics that triggered the compliance breach. Without the full text of the financial results, we cannot determine whether the earnings themselves were positive or negative, but the compliance issue dominates the narrative and explains the outsized single-day loss.

HEPA

Hepion Pharmaceuticals IncHealthcare

$0.05−$0.01

-14.1%

NASDAQ · Mkt cap $5.5 M

No news headlines were found in the last 48 hours to explain the 14% drop in HEPA stock; the decline likely reflects biotech sector weakness, clinical trial setbacks, or other developments not yet captured in public feeds.

Hepion Pharmaceuticals is a small-cap biotech firm, and no relevant headlines appear in the Yahoo Finance RSS for the past two days. Without news coverage of earnings, FDA decisions, trial results, financing announcements, or management changes, the precise catalyst for a 14% single-day decline cannot be identified from the data provided. Biotech stocks, especially micro-cap names trading near penny-stock levels, are prone to sharp moves on clinical or regulatory disappointments that may circulate on specialized channels before hitting mainstream financial news. Alternatively, the drop could reflect broad sector rotation, short covering, or technical selling near support levels. The stock's very low price and substantial loss ranking suggest heightened volatility is inherent to the name.

LABT

Lakewood-Amedex Biotherapeutics Inc.Healthcare

$3.02−$0.47

-14.0%

NASDAQ · Mkt cap $3.8 M

LABT fell 13.95% on news of Nu-3 resistance data presented to a presidential advisory council on antibiotic resistance, likely disappointing investors expecting stronger clinical efficacy results for the company's antimicrobial pipeline.

On July 22, Lakewood-Amedex announced Nu-3 resistance data in response to the National Action Plan of the Presidential Advisory Council on Combating Antibiotic Resistant Bacteria. The headline does not disclose the actual data results, efficacy metrics, or competitive positioning of the Nu-3 compound. For a clinical-stage biotech company, market perception of clinical data is extremely sensitive; a large single-day drop following a data release typically signals investor disappointment relative to prior expectations. The framing as a "response to" a national action plan rather than a breakthrough claim suggests the data may have been reactive or positioned defensively. Without access to the full press release details, the most reasonable inference is that the disclosed resistance profile, potency, or breadth-of-spectrum results fell short of what the market had priced in.

CYH

Community Health Systems IncHealthcare

$2.78−$0.45

-13.8%

NYSE · Mkt cap $424 M

Community Health Systems reported Q2 earnings and revenue below expectations while slashing full-year 2026 guidance, citing higher uninsured volumes and weaker elective surgical demand, triggering the 13.82% stock decline.

CYH's earnings miss was accompanied by a wider-than-expected Q2 loss and materially reduced full-year outlook across revenue, EBITDA, and earnings. The company explicitly blamed operational headwinds including elevated uninsured patient volumes and declining commercial elective surgical demand, both indicators of deteriorating business fundamentals and pricing power. Revenue underperformed estimates by 2.54% while earnings missed by 5.56%, and the forward guidance cut signals management expects these pressures to persist. For a healthcare operator trading near $2.78, such a combination of negative surprises and reduced future expectations typically triggers sharp sell-offs, as investors reassess near-term cash generation and profitability.

QFTA

Quantum FinTech Acquisition CorporationFinancial Services

$0.18−$0.03

-13.7%